MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/circgenetics.116.001631

Медицинская библиотека · Circulation. Cardiovascular genetics · 2017

Lamin A/C-Related Cardiac Disease: Late Onset With a Variable and Mild Phenotype in a Large Cohort of Patients With the Lamin A/C p.(Arg331Gln) Founder Mutation.

Hoorntje Edgar T, Bollen Ilse A, Barge-Schaapveld Daniela Q, van Tienen Florence H, Te Meerman Gerard J, Jansweijer Joeri A, van Essen Anthonie J, Volders Paul G, Constantinescu Alina A, van den Akker Peter C, van Spaendonck-Zwarts Karin Y, Oldenburg Rogier A, Marcelis Carlo L, van der Smagt Jasper J, Hennekam Eric A, Vink Aryan, Bootsma Marianne, Aten Emmelien, Wilde Arthur A, van den Wijngaard Arthur, Broers Jos L, Jongbloed Jan D, van der Velden Jolanda, van den Berg Maarten P, van Tintelen J Peter

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Interpretation of missense variants can be especially difficult when the variant is also found in control populations. This is what we encountered for the LMNA c.992G>A (p.(Arg331Gln)) variant. Therefore, to evaluate the effect of this variant, we combined an evaluation of clinical data with functional experiments and morphological studies.

METHODS AND

RESULTS

Clinical data of 23 probands and 35 family members carrying this variant were retrospectively collected. A time-to-event analysis was performed to compare the course of the disease with carriers of other LMNA mutations. Myocardial biopsies were studied with electron microscopy and by measuring force development of the sarcomeres. Morphology of the nuclear envelope was assessed with immunofluorescence on cultured fibroblasts. The phenotype in probands and family members was characterized by atrioventricular conduction disturbances (61% and 44%, respectively), supraventricular arrhythmias (69% and 52%, respectively), and dilated cardiomyopathy (74% and 14%, respectively). LMNA p.(Arg331Gln) carriers had a significantly better outcome regarding the composite end point (malignant ventricular arrhythmias, end-stage heart failure, or death) compared with carriers of other pathogenic LMNA mutations. A shared haplotype of 1 Mb around LMNA suggested a common founder. The combined logarithm of the odds score was 3.46. Force development in membrane-permeabilized cardiomyocytes was reduced because of decreased myofibril density. Structural nuclear LMNA-associated envelope abnormalities, that is, blebs, were confirmed by electron microscopy and immunofluorescence microscopy.

CONCLUSIONS

Clinical, morphological, functional, haplotype, and segregation data all indicate that LMNA p.(Arg331Gln) is a pathogenic founder mutation with a phenotype reminiscent of other LMNA mutations but with a more benign course.

Для цитирования: Hoorntje Edgar T, Bollen Ilse A, Barge-Schaapveld Daniela Q, van Tienen Florence H, Te Meerman Gerard J, Jansweijer Joeri A, van Essen Anthonie J, Volders Paul G, Constantinescu Alina A, van den Akker Peter C, van Spaendonck-Zwarts Karin Y, Oldenburg Rogier A, Marcelis Carlo L, van der Smagt Jasper J, Hennekam Eric A, Vink Aryan, Bootsma Marianne, Aten Emmelien, Wilde Arthur A, van den Wijngaard Arthur, Broers Jos L, Jongbloed Jan D, van der Velden Jolanda, van den Berg Maarten P, van Tintelen J Peter. Lamin A/C-Related Cardiac Disease: Late Onset With a Variable and Mild Phenotype in a Large Cohort of Patients With the Lamin A/C p.(Arg331Gln) Founder Mutation.. Circulation. Cardiovascular genetics. 2017. DOI: 10.1161/circgenetics.116.001631.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.